Boston Scientific Sells California Unit

Boston Scientific is selling its California-based TriVascular endovascular aortic repair (EVAR) program to TV2 Holding Co. Boston Scientific acquired TriVascular, a manufacturer of EVAR devices, in April 2005 and renamed it Boston Scientific Santa Rosa. The company discontinued the EVAR program in 2006. Boston Scientific said TV2 will pay it $30 million at closing. It may retain a minority interest in the company. SOURCE: FDAnews.com

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters